Related Experiment Video
Updated: Jan 18, 2026

13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
4.1K
[pT1c Breast Cancer Presenting with Skin Rupture without Skin Invasion-A Case Report]
Akimasa Nishimura1, Misako Yatsuyanagi
1Dept. of Breast Surgery, Saitama City Hospital.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 17, 2026
Summary
This case study highlights breast bleeding as an unusual symptom of breast cancer, even without skin involvement. Early detection and treatment, including surgery and adjuvant therapies, are crucial for successful outcomes in invasive ductal carcinoma.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Breast bleeding is an uncommon presentation of breast cancer.
- Malignant breast masses may not always present with visible skin changes.
Purpose of the Study:
- To report a rare case of breast cancer presenting solely with bleeding.
- To emphasize the importance of clinical suspicion in diagnosing breast cancer.
Main Methods:
- A case report of a female patient in her 70s with a history of untreated breast mass.
- Diagnostic procedures included clinical examination, needle biopsy, and subsequent lumpectomy with sentinel lymph node biopsy.
- Pathological analysis confirmed invasive ductal carcinoma.
Main Results:
- The patient presented with recurrent breast bleeding, initially misdiagnosed by needle biopsy.
- Pathological examination revealed invasive ductal carcinoma (pT1c, pN0 (sn), M0, pStageⅠ) without skin invasion.
- Post-surgical treatment with tamoxifen and radiation therapy resulted in no recurrence.
Conclusions:
- Breast bleeding can be the primary sign of breast cancer, even without skin invasion.
- Clinical diagnosis and thorough pathological evaluation are essential for accurate breast cancer staging and treatment planning.
- Adjuvant therapy plays a vital role in preventing recurrence of early-stage breast cancer.
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
